Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor

Full text
Author(s):
Diniz, Gabriela Placona [1] ; Lino, Caroline Antunes [1] ; Guedes, Elaine Castilho [1] ; Moreira, Luana do Nascimento [1] ; Morais Barreto-Chaves, Maria Luiza [1]
Total Authors: 5
Affiliation:
[1] Univ Sao Paulo, Lab Cell Biol & Funct Anat, Dept Anat, Inst Biomed Sci, BR-05508900 Sao Paulo, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: BASIC RESEARCH IN CARDIOLOGY; v. 110, n. 5 SEP 2015.
Web of Science Citations: 18
Abstract

Elevated thyroid hormone (TH) levels induce cardiac hypertrophy partially via type 1 Angiotensin II receptor (AT1R). MicroRNAs (miRNAs) are key regulators of cardiac homeostasis, and miR-133 has been shown to be involved in cardiac hypertrophy. However, the potential role of miR-133 in cardiac growth induced by TH is unknown. Thus, we aimed to investigate the miR-133 expression, as well as its potential role in cardiac hypertrophy in response to TH. Wistar rats were subjected to hyperthyroidism combined or not with the AT1R blocker. T-3 serum levels were assessed to confirm the hyperthyroid status. TH induced cardiac hypertrophy, as evidenced by higher cardiac weight/tibia length ratio and alpha-actin mRNA levels, which was prevented by AT1R blocker. miR-133 expression was decreased in TH-induced cardiac hypertrophy in part through the AT1R. Additionally, the cardiac mRNA levels of miR-133 targets, SERCA2a and calcineurin were increased in hyperthyroidism partially via AT1R, as evaluated by real-time RT-PCR. Interestingly, miR-133 levels were unchanged in T-3-induced cardiomyocyte hypertrophy in vitro. However, a gain-of-function study revealed that miR-133 mimic blunted the T-3-induced cardiomyocyte hypertrophy in vitro. Together, our data indicate that miR-133 expression is reduced in TH-induced cardiac hypertrophy partially by the AT1R and that miR-133 mimic prevents the cardiomyocyte hypertrophy in response to T-3 in vitro. These findings provide new insights regarding the mechanisms involved in the cardiac growth mediated by TH, suggesting that miR-133 plays a key role in TH-induced cardiomyocyte hypertrophy. (AU)

FAPESP's process: 09/14567-7 - Analysis of microRNAs expression on cardiac hypertrophy induced by thyroid hormone, "in vivo" and "in vitro". role of AT1 receptor
Grantee:Gabriela Placoná Diniz
Support Opportunities: Scholarships in Brazil - Post-Doctoral